Long-term outcomes for infants with very low risk wilms tumor treated with surgery alone in national wilms tumor study-5

Annals of Surgery

Volumn 251, Issue 3, 2010, Pages 555-558

  Shamberger, Robert C ^a   Anderson, James R ^b   Breslow, Norman E ^c   Perlman, Elizabeth J ^d   Beckwith, J Bruce ^e   Ritchey, Michael L ^f   Haase, Gerald M ^g   Donaldson, Milton ^h   Grundy, Paul E ⁱ   Weetman, Robert ^j   Coppes, Max J ^k   Malogolowkin, Marcio ^l   Shearer, Patricia D ^m   Kletzel, Morris ⁿ   Thomas, Patrick R M ^o   MacKlis, Roger ^p   Huff, Vicki ^q   Weeks, Douglas A ^r   Green, Daniel M ^s  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d CHILDREN'S MEMORIAL HOSPITAL   (United States)

^e LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MAYO CLINIC   (United States)

^g CHILDREN S HOSPITAL   (United States)

^h UMDNJ Robert Wood Johnson Medical School at Camden   (United States)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

^j INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^l CHILDREN S HOSPITAL LOS ANGELES   (United States)

^m UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

ⁿ NORTHWESTERN UNIVERSITY   (United States)

^o ST JOSEPH HOSPITAL   (United States)

^p LERNER RESEARCH INSTITUTE   (United States)

^q UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^r OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^s ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ARTICLE; CANCER STAGING; CONTROLLED STUDY; EVENT FREE SURVIVAL; FOLLOW UP; GROUPS BY AGE; HISTOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MORTALITY; NEPHROBLASTOMA; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS;

HUMANS; INFANT; KIDNEY NEOPLASMS; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; WILMS TUMOR;

EID: 77649087994     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181c0e5d7     Document Type: Article

References (18)

1. Green DM, Breslow N, Beckwith JB, et al. Treatment with nephrectomy only for small, stage I/Favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 2001;19:3719-3724. (Pubitemid 32844783)
2. Green D, Cotton C, Malogolowkin M, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2007;48:493-499.
3. Malogolowkin MH, Feusner J, Steele DA, et al. Carboplatin (CBDCA)/ Etoposide (VP-16) for the treatment of children with high-risk (HR) or recurrent Wilms' tumor (RWT). ASCO. 1994;13:424.
4. Farber S, D'Angio GJ, Evans A, et al. Clinical studies of actinomycin D with special reference to Wilms' Tumor in children. Ann NY Acad Sci. 1960;89: 421-425.
5. Farber S. Chemotherapy in the treatment of leukemia and Wilms' tumor. JAMA. 1966;198:826-836.
6. Garcia M, Douglass EC, Schlosser JV. Classification and prognosis in Wilms' tumor. Radiology. 1963;80:574-580.
7. Cassady JR, Tefft M, Filler RM, et al. Considerations in the radiation therapy of Wilms' tumor. Cancer. 1973;32:598-608.
8. Green DM, Jaffe N. The role of chemotherapy in the treatment of Wilms' tumor. Cancer. 1979;44:52-57.
9. Green DM, Breslow NE, Beckwith JB, et al. Treatment outcomes in patients less than 2 years of age with small, Stage I, favorable-histology Wilms' tumors: a report from the National Wilms' Tumor Study. J Clin Oncol. 1993;11:91-95.
10. Larsen E, Perez-Atayde AR, Green DM. Surgery only for the treatment of patients with stage I (Cassady) Wilms' tumor. Cancer. 1990;66:264-266.
11. Shamberger RC, Macklis RM, Sallan SE. Recent experience with Wilms' tumor: 1978-1991. Ann Surg Oncol. 1994;1:59-65.
12. Weeks DA, Beckwith B, Luckey DW. Relapse-associated variables in Stage I favorable histology Wilms' tumor: a report of the National Wilms' Tumor Study. Cancer. 1987;60:1204-1212.
13. Green DM, Beckwith JB, Weeks DA, et al. The relationship between microsubstaging variables, age at diagnosis, and tumor weight of children with Stage I/favorable histology Wilms' tumor: a report from the National Wilms' tumor study. Cancer. 1994;74:1817-1820.
14. Breslow NE, Beckwith JB, Haase GM, et al. Radiation therapy for favorable histology Wilms tumor: prevention of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4. Int J Radiat Oncol Biol Phy. 2006;65:203-209.
15. Green DM, Finklestein JZ, Norkool P, et al. Severe hepatic toxicity after treatment with single dose dactinomycin and vincristine. Cancer. 1988;62: 270-273.
16. Green DM, Norkool P, Breslow N, et al. Severe hepatic toxicity after treatment with vincristine and actinomycin D using single-dose or divided dose schedule. J Clin Oncol. 1990;8:1525-1530.
17. Green DM, Breslow NE, Beckwith JB, et al. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 1998;16:3744-3751.
18. Hudson MM, Mertens AC, Yasui Y, et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA. 2009;290:1583-1592.